US Stock MarketDetailed Quotes

TARS Tarsus Pharmaceuticals

Watchlist
  • 27.140
  • +0.100+0.37%
Close Jul 22 16:00 ET
  • 27.140
  • 0.0000.00%
Post 16:20 ET
1.03BMarket Cap-5713P/E (TTM)

Tarsus Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Tarsus Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

27.61M

+1004.56%
EPS(YoY)

-1.01

-14.77%
Analyst Rating

Strong Buy

Jul 22, 2024

Tarsus Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 38.912M--
--2024/Q2-- / 32.353M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
Nov 9, 20232023/Q31.871M / 361.000K--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 38.912M--
--2024/Q2-- / 32.353M--
May 8, 20242024/Q127.614M / 17.898M--
Feb 27, 20242023/Q413.076M / 5.924M--
Nov 9, 20232023/Q31.871M / 361.000K--

Unlock Free Earnings Estimates

Tarsus Pharmaceuticals Earnings Reports

  • Tarsus Pharmaceuticals | 10-Q: Quarterly report

    May 8 17:19 ET

  • Tarsus Pharmaceuticals | 10-K: Annual report

    Feb 27 16:10 ET

  • Tarsus Pharmaceuticals: Q3 2023 Earnings Report

    Nov 9, 2023 16:00 ET

  • Tarsus Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 10, 2023 16:12 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      100.00%

    • Hold

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg